An alarming public health concern over variability in herbal compositions of marketed immunity booster products during COVID-19: A botanical survey-based study

Chirag Kalal; Sanket Charola

doi:10.52756/ijerr.2021.v24.005

Authors

Chirag Kalal Department of Botany, Faculty of Science, TheMaharaja Sayajirao University of Baroda, Gujarat, India
Sanket Charola Department of Botany, Faculty of Science, TheMaharaja Sayajirao University of Baroda, Gujarat, India

DOI:

https://doi.org/10.52756/ijerr.2021.v24.005

Keywords:

COVID-19, herbal products, immunity booster, medicinal plants, product survey

Abstract

The world is going through pandemic of the century named COVID-19 disease. The COVID-19 pathogenesis involves cytokine storm in advanced stage leading to systemic hyper-inflammation. Medicinal herbs are practiced as part of alternative therapies in addition to clinically approved drugs with strong belief of its safety and efficacy. In present times, many herbal immunity booster products are available in market which claims to boost immunity for fighting against COVID-19 in prevention and cure. In this study, herbal products with tag of Immunity boosters were surveyed from medical stores and studied for their botanical contents. We surveyed 60 herbal products out of which 31% were tablets and rest were other forms like capsule, decoction and avaleha. Among the products, 17% products were from Dabur followed by Himalaya, Zandu and rest other leading brands of herbal market. Total 98 plants belonging to 50 diverse plant families like Zingiberaceae, Lamiaceae, Piperaceae and Apiaceae were reported being used in these products. Including Fruits (19%), Root (18%) and Leaf (17%), total 20 different plant parts were found used as medicinal herbs. These herbal products were having 10.27 ± 14.02 herbs with range of 56 indicates huge ingredient variation among the products. This diversity in products poses serious health concern in buyers who do not know the safety and efficacy of immunity boosters, being used in COVID-19 pandemic.

References

Aggarwal, B. B., Van Kuiken, M. E., Iyer, L. H., Harikumar, K. B. and Sung, B. (2009). Molecular targets of nutraceuticals derived from dietary spices: Potential role in suppression of inflammation and tumorigenesis. Experimental Biology and Medicine. 234 (8): 825–849.

Al-Rohaimi, A. H. and Al Otaibi, F. (2020). Novel SARS-CoV-2 outbreak and COVID19 disease; a systemic review on the global pandemic. Genes and Diseases. 7 (4): 491–501.

Bhattacharya, R., Dev, K. and Sourirajan, A. (2021). Antiviral activity of bioactive phytocompounds against coronavirus: An update. Journal of Virological Methods. 290: 114070.

Boozari, M. and Hosseinzadeh, H. (2021). Natural products for COVID-19 prevention and treatment regarding to previous coronavirus infections and novel studies. Phytotherapy Research. 35 (2): 864–876.

Cassa Macedo, A., Oliveira Vilela de Faria, A. and Ghezzi, P. (2019). Boosting the Immune System, From Science to Myth: Analysis the Infosphere With Google. Frontiers in Medicine. 6: 165. Fidl, D. P. (2020). Vaccine nationalism’s politics. Science. 369 (6505): 749.

Gautam, S., Gautam, A., Chhetri, S. and Bhattarai, U. (2020). Immunity against COVID-19: Potential role of Ayush Kwath. Journal of Ayurveda and Integrative Medicine. Ghasemian, M., Owlia, S. and Owlia, M. B. (2016). Review of Anti-Inflammatory Herbal Medicines. Advances in Pharmacological Sciences. 2016: 1-16.

Green, G. A., Catlin, D. H. and Starcevic, B. (2001). Analysis of over-the-counter dietary supplements. Clinical Journal of Sport Medicine. 11 (4): 254–259.

Ichikawa, H., Wang, X. and Konishi, T. (2003). Role of component herbs in antioxidant activity of Shengmai San - A traditional Chinese medicine formula preventing cerebral oxidative damage in rat. American Journal of Chinese Medicine. 31 (4): 509–521.

Islam, M. T., Sarkar, C., El-Kersh, D. M., Jamaddar, S., Uddin, S. J., Shilpi, J. A. and Mubarak, M. S. (2020). Natural products and their derivatives against coronavirus: A review of the non-clinical and pre-clinical data. Phytotherapy Research. 34 (10): 2471–2492.

Jayawardena, R., Sooriyaarachchi, P., Chourdakis, M., Jeewandara, C. and Ranasinghe, P. (2020). Enhancing immunity in viral infections, with special emphasis on COVID-19: A review. Diabetes and Metabolic Syndrome: Clinical Research and Reviews. 14 (4): 367–382.

Karole, S., Shrivastava, S., Thomas, S., Soni, B., Khan, S., Dubey, J., Dubey, S. P., Khan, N. and Jain, D. K. (2019). Polyherbal Formulation Concept for Synergic Action: A Review. Journal of Drug Delivery and Therapeutics. 9(1-s): 453–466.

Khatami, M. (2009). Inflammation, aging, and cancer: Tumoricidal versus tumorigenesis of immunity. Cell Biochemistry and Biophysics. 55(2): 55–79.

Mahapatra, S. and Chandra, P. (2020). Clinically practiced and commercially viable nanobio engineered analytical methods for COVID-19 diagnosis. Biosensors and Bioelectronics. 165: 112361.

Mehta, P., McAuley, D. F., Brown, M., Sanchez, E., Tattersall, R. S. and Manson, J. J. (2020). COVID-19: consider cytokine storm syndromes and immunosuppression. The Lancet. 395 (10229): 1033–1034.

Meyer, H. (2020). After a COVID-19 vaccine: Collaboration or competition? Health Affairs. 39 (11): 1856–1860. Ogbunugafor, H. A., Ugochukwu, C. G. and Kyrian-Ogbonna, A. E. (2017). The role of spices in nutrition and health: a review of three popular spices used in Southern Nigeria. Food Quality and Safety. 1 (3): 171–185.

Pan, M. H., Chiou, Y. S., Tsai, M. L. and Ho, C. T. (2011). Anti-inflammatory activity of traditional chinese medicinal herbs. Journal of Traditional and Complementary Medicine. 1 (1): 8–24.

Pan, W., Liu, Y., Fang, Z., Zhu, X., Pan, W., Kwak, S. and Yamamoto, Y. (2011). A compound belonging to traditional Chinese medicine improves nocturnal activity in Parkinson’s disease. Sleep Medicine. 12 (3): 307–308.

Qin, C., Zhou, L., Hu, Z., Zhang, S., Yang, S., Tao, Y., Xie, C., Ma, K., Shang, K., Wang, W. and Tian, D. S. (2020). Dysregulation of immune response in patients with coronavirus 2019 (COVID-19) in Wuhan, China. Clinical Infectious Diseases. 71 (15): 762–768.

Rappuoli, R., Pizza, M., Del Giudice, G. and De Gregorio, E. (2014). Vaccines, new opportunities for a new society. Proceedings of the National Academy of Sciences of the United States of America. 111 (34): 12288–12293.

Rathore, B., Mahdi, A. A., Paul, B. N., Saxena, P. N. and Das, S. K. (2007). Indian herbal medicines: Possible potent therapeutic agents for rheumatoid arthritis. Journal of Clinical Biochemistry and Nutrition. 41 (1): 12–17.

Ren, Y., Qiao, W., Fu, D., Han, Z., Liu, W., Ye, W. and Liu, Z. (2017). Traditional Chinese Medicine Protects against Cytokine Production as the Potential Immunosuppressive Agents in Atherosclerosis. Journal of Immunology Research. 2017: 1-8.

Rothan, H. A. and Byrareddy, S. N. (2020). The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak. Journal of Autoimmunity. 109: 102433.

RStudio Team. (2021). RStudio: Integrated Development Environment for R. PBC, Boston, MA. URLhttp://www.rstudio.com/ Sahoo, N. and Manchikanti, P. (2013). Herbal drug regulation and commercialization: An indian industry perspective. Journal of Alternative and Complementary Medicine. 19 (12): 957–963.

Sharma, R., Martins, N., Kuca, K., Chaudhary, A., Kabra, A., Rao, M. M. and Prajapati, P. K. (2019). Chyawanprash: A traditional indian bioactive health supplement. Biomolecules. 9 (5): 1-24.

Siddiqi, H. K. and Mehra, M. R. (2020). COVID-19 illness in native and immunosuppressed states: A clinical–therapeutic staging proposal. In Journal of Heart and Lung Transplantation. 39 (5): 405–407.

Singh, N. A., Kumar, P., Jyoti, and Kumar, N. (2021). Spices and herbs: Potential antiviral preventives and immunity boosters during COVID‐19. Phytotherapy Research. 7019.

Singh, N., Tailand, M. and Mehta, S. C. (2016). A review on herbal plants as immunomodulators . International Journal of Pharmaceutical Sciences and Research. 7 (9): 3602–3610.

Sree Lakshmi, S. B. and Geetha, R. V. (2020). Knowledge and awareness about natural immune booster among general public. International Journal of Research in Pharmaceutical Sciences, 11 (3): 1156–1164.

Tachjian, A., Maria, V. and Jahangir, A. (2010). Use of Herbal Products and Potential Interactions in Patients With Cardiovascular Diseases. Journal of the American College of Cardiology. 55 (6): 515–525.

Wagner, D. N., Marcon, A. R. and Caulfield, T. (2020). 'Immune Boosting' in the time of COVID: Selling immunity on Instagram. Allergy, Asthma and Clinical Immunology. 16 (1): 76.

Winkler, L. (2021). COVID-19 purchase behaviour shifts: assortment and portfolio implications 2021. https://www.kantar.com/inspiration/coronavirus/covid-19-purchase-behaviour-shifts-assortment-and-portfolio-implications-2021.

Wu, C., Chen, X., Cai, Y., Xia, J., Zhou, X., Xu, S., Huang, H., Zhang, L., Zhou, X., Du, C., Zhang, Y., Song, J., Wang, S., Chao, Y., Yang, Z., Xu, J., Zhou, X., Chen, D., Xiong, W. and Song, Y. (2020). Risk Factors Associated with Acute Respiratory Distress Syndrome and Death in Patients with Coronavirus Disease 2019 Pneumonia in Wuhan, China. JAMA Internal Medicine. 180 (7): 934–943.

Yuen, K. S., Ye, Z. W., Fung, S. Y., Chan, C. P. and Jin, D. Y. (2020). SARS-CoV-2 and COVID-19: The most important research questions. Cell and Bioscience. 10 (40): 1-5.